Liver fibrosis and hepatitis B coinfection among ART Na\ve HIV-infected patients at a tertiary level hospital in Northwestern Tanzania: a cross-sectional study

Show simple item record

dc.contributor.author Kilonzo, Semvua B.
dc.contributor.author Gunda, Daniel W.
dc.contributor.author Kashasha, Flora
dc.contributor.author Mpondo, Bonaventura C.
dc.date.accessioned 2021-08-31T08:04:36Z
dc.date.available 2021-08-31T08:04:36Z
dc.date.issued 2017
dc.identifier.citation Kilonzo, S. B., Gunda, D. W., Kashasha, F., & Mpondo, B. C. (2017). Liver fibrosis and Hepatitis B coinfection among ART Naive HIV-infected patients at a tertiary level hospital in Northwestern Tanzania: a cross-sectional study. Journal of Tropical Medicine, 2017. en_US
dc.identifier.other DOI:10.1155/2017/5629130
dc.identifier.uri http://hdl.handle.net/20.500.12661/3305
dc.description Full text article. Also available at https://doi.org/10.1155/2017/5629130 en_US
dc.description.abstract Liver fibrosis which is a common complication of chronic hepatitis B infection is rarely diagnosed in low-resource countries due to limited capacity to perform biopsy studies. Data on the utilization of noninvasive techniques which are feasible for diagnosis of liver fibrosis in these settings among HIV-infected patients is scarce. The objective of this study was to establish the magnitude of liver fibrosis by using both aspartate-aminotransferase-to-platelets ratio and fibrosis-4 scores with associated hepatitis B coinfection among antiretroviral therapy naïve HIV-infected patients. We reviewed data of 743 adult patients attending HIV clinic with available hepatitis B surface antigen test results. Baseline clinical information was recorded and aspartate-aminotransferase-to-platelet ratio and fibrosis-4 scores were calculated. The cut-off values of 1.5 and 3.25 were used for diagnosis of significant fibrosis by aspartate-aminotransferase-to-platelets ratio and fibrosis-4 scores, respectively. Results. The prevalence of liver fibrosis was 3.5% when aspartate-aminotransferase-to-platelet score was used and 4.6% with fibrosis-4 score and they were both significantly higher among patients with hepatitis B coinfection. Younger patients with HIV advanced disease and elevated liver transaminases had increased risk of having hepatitis B coinfection. A remarkable number of HIV-infected patients present with liver fibrosis, predominantly those with hepatitis B infection. en_US
dc.language.iso en en_US
dc.publisher Hindawi en_US
dc.subject Fibrosis en_US
dc.subject Liver fibrosis en_US
dc.subject Hepatitis en_US
dc.subject Hepatitis B coinfection en_US
dc.subject ART naïve HIV-infected patients en_US
dc.subject HIV-infected patients en_US
dc.subject Antiretroviral therapy en_US
dc.subject Hepatitis B virus en_US
dc.subject HBV en_US
dc.subject Liver fibrosis en_US
dc.subject Chronic hepatitis en_US
dc.subject Liver biopsy en_US
dc.title Liver fibrosis and hepatitis B coinfection among ART Na\ve HIV-infected patients at a tertiary level hospital in Northwestern Tanzania: a cross-sectional study en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search UDOM-IR


Browse

My Account